Mike Hencke | Director, Investor Relations |
Michel Vounatsos | Chief Executive Officer |
Al Sandrock | Head of Research and Development |
Mike McDonnell | Chief Financial Officer |
Michael Yee | Jefferies |
Ronny Gal | Bernstein |
Marc Goodman | SVB Leerink |
Yatin Suneja | Guggenheim Partners |
Umer Raffat | Evercore |
Matthew Harrison | Morgan Stanley |
Brian Abrahams | RBC Capital Markets |
Colin Bristow | UBS |
Evan Seigerman | Credit Suisse |
Jay Olson | Oppenheimer |
Geoff Meacham | Bank of America |
Sumant Kulkarni | Canaccord |
Good morning. My name is [Ashley], and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter Earnings Call and Financial Update. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session.